IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 217 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $13,248,000 | -13.8% | 1,382,900 | -0.7% | 0.27% | -23.8% |
| Q2 2022 | $15,371,000 | -84.7% | 1,392,300 | -77.0% | 0.35% | -83.2% |
| Q1 2022 | $100,620,000 | +39.4% | 6,043,219 | +59.9% | 2.10% | +36.9% |
| Q4 2021 | $72,160,000 | +100.1% | 3,780,000 | +158.5% | 1.53% | +91.5% |
| Q3 2021 | $36,058,000 | +37.1% | 1,462,200 | +83.0% | 0.80% | -34.5% |
| Q3 2020 | $26,303,000 | +29.7% | 799,000 | +8.2% | 1.22% | -6.1% |
| Q2 2020 | $20,273,000 | – | 738,547 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |